No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
Pfizer and Amazon Explore Collaboration With RFK Jr. on Climate and Health Crisis
CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal
Are Pfizer Inc.'s (NYSE:PFE) Mixed Financials Driving The Negative Sentiment?
Express News | Pfizer Inc - Overall Survival Data Not yet Mature
Pfizer's IBRANCE in Combination With Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 PATINA Study in Patients With HR+, HER2+ Metastatic Breast Cancer